Key Points from the SEC 8-K Filing

• Corebridge Financial, Inc. has entered into a Material Definitive Agreement with Equitable Holdings, Inc. and Nippon Life Insurance Company, as disclosed in its current report dated April 8, 2026.
• The agreement is a Voting and Support Agreement, which governs the voting of shares and support for a proposed transaction between Corebridge and Equitable Holdings.
• Nippon Life Insurance Company (NLI) is a major shareholder, holding 121,992,454 shares of Corebridge common stock.
• All parties have made extensive representations and warranties regarding their organizational status, authority, and compliance with regulatory requirements.
• Shareholder approval is a key condition for the transaction, along with regulatory filings and consents.
• The agreement includes comprehensive restrictions on share transfers, tender offers, and acquisition proposals by Nippon Life, which will be price-sensitive for investors.
• Confidentiality and insider trading restrictions are imposed on NLI regarding material non-public information.
• Corporate governance changes are outlined, including board composition, committee rights, and approval requirements for key actions.
• Corebridge will reimburse NLI for reasonable documented expenses incurred in connection with the agreement and the transaction.

Details of the Proposed Transaction and Shareholder Agreements

• Voting Commitment: NLI has agreed to vote all of its shares in favor of the proposed transaction and related actions, and not to transfer shares or enter into voting agreements with third parties, except under certain conditions.
• No Solicitation: NLI and its subsidiaries are restricted from soliciting, encouraging, or negotiating alternative acquisition proposals, except in response to bona fide unsolicited offers where Corebridge is permitted to engage under the merger agreement.
• Regulatory Efforts: NLI will use its best efforts to assist Corebridge and Equitable in obtaining all necessary regulatory approvals and consents. This includes prompt filing with governmental entities and sharing substantive communications regarding the transaction.
• Corporate Governance: The agreement specifies board composition, including NLI’s right to designate directors. Board observers and committee participation are also covered, with requirements for confidentiality and compliance with company policies.
• Actions Requiring NLI Consent Prior to Sunset Date: The company must obtain NLI’s prior written consent for any amendment to the charter, voluntary delisting, issuing shares to competitors, and other significant corporate actions.
• Share Ownership Limitation: NLI and its affiliates are restricted from increasing their share ownership above 30% without board approval, and from forming groups for acquisition or voting purposes.
• Access and Information Rights: As long as NLI holds at least 10% of Corebridge shares, it will have broad access to books, records, personnel, and systems for regulatory and financial compliance purposes.
• Expense Reimbursement: Corebridge will reimburse NLI for reasonable legal and third-party expenses related to the agreement and transaction.

Potentially Price-Sensitive Information for Shareholders

• Large Shareholder Voting Commitment: NLI’s agreement to vote its substantial holding (over 121 million shares) in favor of the transaction could significantly impact the outcome of shareholder votes, making the deal very likely to proceed.
• Restrictions on Share Transfers: NLI cannot transfer or sell its shares except under limited circumstances, reducing the risk of market overhang or instability from large share sales.
• Corporate Governance Changes: NLI’s board designation and committee rights may influence future strategic direction, risk oversight, and management decisions at Corebridge.
• Regulatory and Transaction Uncertainties: Completion of the transaction is subject to regulatory approvals and other conditions, which are material risks for investors. Failure to secure approvals or shareholder support would prevent the deal from closing.
• Expense Reimbursement: The arrangement for expense reimbursement could affect Corebridge’s short-term cash flows and financial statements.
• Forward-Looking Statements: The filing contains cautionary language regarding forward-looking statements, emphasizing uncertainties and risks, including the ability to complete the transaction, realization of synergies, and regulatory matters.

Summary for Investors

Corebridge Financial, Inc. has announced an important shareholder agreement with Equitable Holdings and Nippon Life Insurance Company that will directly affect the voting and support for a major transaction between Corebridge and Equitable. Nippon Life, as a substantial shareholder, has committed to vote all its shares in favor of the transaction and is subject to extensive restrictions regarding share transfers, solicitation, and corporate actions, which will stabilize the shareholder base and governance.

The agreement outlines significant corporate governance changes, including NLI’s rights regarding board representation and approval of major actions. These provisions could impact Corebridge’s future strategy and management. The deal is contingent on shareholder approval and regulatory consents, and contains provisions for forward-looking risk disclosure.

Investors should closely monitor further announcements on regulatory progress, shareholder meetings, and the completion timeline for the transaction, as these events are likely to be price-sensitive and may drive share value.